Mirati Therapeutics, Inc. MRTX

Full chart Compare
Set alert

Price alert · MRTX

All alert types
58.70 0.00 (+0.00%)

At closeJan 22, 2024, 4:00 PM EST

58.54 Day range 58.99

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $19.23MExpenses → Selling, General & Admin: $239.80MExpenses → Research & Development: $531.63MExpenses → Income Tax: $508.00KGross Profit → Expenses: $11.84MRevenue → Gross Profit: $11.84MRevenue → Cost of Revenue: $600.00KNet Loss → Expenses: $740.87MOther Income$19.23MGross Profit$11.84MNet Loss$740.87MCost of Revenue$600.00KExpenses$771.93MSelling, General & Admin$239.80MResearch & Development$531.63MIncome Tax$508.00KRevenue$12.44M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

MRTX annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
12.44M72.09M13.40M3.33M12.93M
12.44M72.09M13.40M3.33M12.93M
600.00K0000
11.84M72.09M13.40M3.33M12.93M
771.42M645.27M382.76M225.44M115.55M
531.63M508.59M299.35M182.87M93.87M
239.80M136.68M83.41M42.57M21.68M
-759.59M-573.18M-369.36M-222.10M-102.63M
508.00K3.30M000
-740.87M-581.78M-357.94M-213.26M-98.42M
-740.87M-581.78M-357.94M-213.26M-98.42M
-740.87M-581.78M-357.94M-213.26M-98.42M
-740.87M-581.78M-357.94M-213.26M-98.42M
-13.18-11.21-7.96-5.69-3.19
-13.18-11.21-7.96-5.69-3.19
-13.18-11.21-7.96-5.69-3.19
-740.36M-578.49M-357.94M-213.26M-98.42M
-740.36M-578.49M-357.94M-213.26M-98.42M
56.23M51.88M44.99M37.47M30.90M
56.23M51.88M44.99M37.47M30.90M